BOLD MRI: Application to Intra-renal Oxygenation

BOLD MRI:在肾内氧合中的应用

基本信息

项目摘要

Radiocontrast nephropathy (RCN) is a third common cause of hospital acquired renal failure, accounting for 11% of incidence. With the continuing rise in the number of diagnostic imaging procedures and because it is a hospital acquired syndrome, the need for prevention is most compelling. However, the mechanisms behind the development of RCN remain not fully understood. Many interventions proposed based on animal testing have failed in human trials. The possible reasons for this disconnect may be due to: (1) animal models not adequately representing the human physiology, (2) outcome measures used in animal models differ from those used in the clinic, (3) invalid hypothesis etc.. Over the last two decades significant progress has been made in terms of understanding the oxygenation status within the kidney and it is now well appreciated that regions within the kidney survive under hypoxic conditions. In order for the kidney to survive in the hypoxic milieu, powerful control mechanisms have evolved that maintain oxygen sufficiency even under the threat of external stimuli such as during administration of contrast media. It is believed that compromise in the ability of the kidney to activate these control mechanisms during a "stress" may be the cause for the development of renal failure following stimuli such as contrast media. Based on these hypotheses, novel animal models have been proposed and validated. These are simpler compared to previous models that necessitate surgical manipulations, and more importantly better represent the functional aspect of the human condition. Additionally, the techniques available for monitoring intra-renal oxygenation have continuously improved. Blood oxygenation level dependent (BOLD) MRI technique has been shown to be sensitive and efficacious in evaluating renal oxygenation both in rat and human kidneys. In addition, better understanding of the oxygenation status has given rise to new targets for intervention. Based on this background, this proposal extends our present findings in healthy and hypertensive kidneys with BOLD MRI to better understand the acute hemodynamic responses following contrast administration in functional models of RCN and in RCN prone diabetic rats. We will additionally acquire markers that are used in the clinic. We will also test the efficacy of novel interventions targeted at relieving hypoxia. We will further use sodium MRI to monitor acute changes following contrast media and correlate them with BOLD MRI measurements. Successful outcome should have a significant impact on the development of preventive strategies for RCN. Radiocontrast induced renal failure is a common hospital acquired syndrome and because the consequences could be severe including death, preventive strategies are highly sought after. With the continuous increase in the number diagnostic procedures, the relevance and significance of this problem is growing. Our proposed study will allow for better understanding of the mechanisms behind the development of this syndrome and develop novel preventive strategies.
放射性造影剂肾病(RCN)是导致医院获得性肾功能衰竭的第三种常见原因,占 发病率的11%。随着诊断成像程序数量的持续增加,因为它是一种 医院获得性综合症,预防的必要性是最迫切的。然而,背后的机制 RCN的发展仍然没有得到充分的了解。许多干预措施是基于动物试验提出的 在人体试验中都失败了。这种脱节的可能原因可能是:(1)动物模型没有 充分代表人类生理,(2)动物模型中使用的结果度量与那些 临床应用;(3)假设无效等。 在过去的二十年里,在理解氧合作用方面取得了重大进展。 在肾脏中的地位,现在很好地认识到肾脏内的区域在低氧下存活 条件。为了让肾脏在低氧环境中存活,已经进化出了强大的控制机制。 即使在外部刺激的威胁下也保持氧气充足,例如在给药期间 造影剂。据认为,肾脏激活这些控制机制的能力受损 在“压力”状态下,可能是在对比剂等刺激后发生肾功能衰竭的原因 媒体。 基于这些假设,人们提出了新的动物模型并进行了验证。这些更简单 与以前需要手术操作的模型相比,更重要的是更好地代表了 人类状况的功能方面。此外,可用于监测肾内的技术 氧合作用不断改善。血氧水平依赖(BOLD)MRI技术 已被证明在评估大鼠和人肾脏的肾氧合作用方面是敏感和有效的。在……里面 此外,对氧合状态的更好理解也催生了新的干预目标。 基于这一背景,这项建议扩展了我们目前在健康和高血压肾脏中的发现 BOLD MRI以更好地了解造影剂注射后的急性血流动力学反应 肾小球肾炎和肾小球肾炎倾向糖尿病大鼠功能模型。我们将额外获得使用的标记 在诊所里。我们还将测试针对缓解缺氧的新型干预措施的有效性。我们将进一步 使用钠核磁共振监测造影剂后的急性变化,并将其与BOLD MRI相关联 测量。 成功的结果应对制定区域保护联盟的预防战略产生重大影响。放射性造影剂引起的肾功能衰竭是一种常见的医院获得性综合征,由于其后果 可能是严重的,包括死亡,预防策略备受追捧。随着……的不断增加 诊断程序的数量越来越多,这一问题的相关性和意义越来越大。我们的建议 研究将有助于更好地了解这种综合征发生和发展的机制 制定新的预防策略。

项目成果

期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Intrarenal oxygenation by blood oxygenation level-dependent MRI in contrast nephropathy model: effect of the viscosity and dose.
  • DOI:
    10.1002/jmri.23747
  • 发表时间:
    2012-11
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Li, Lu-Ping;Franklin, Tammy;Du, Hongyan;Papadopoulou-Rosenzweig, Maria;Carbray, Joann;Solomon, Richard;Prasad, Pottumarthi V.
  • 通讯作者:
    Prasad, Pottumarthi V.
Sensitivity of USPIO-enhanced R2 imaging to dynamic blood volume changes in the rat kidney.
USPIO 增强 R2 成像对大鼠肾脏动态血容量变化的敏感性。
Intra-renal oxygenation in rat kidneys during water loading: effects of cyclooxygenase (COX) inhibition and nitric oxide (NO) donation.
  • DOI:
    10.1002/jmri.22253
  • 发表时间:
    2010-08
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Ji, Lin;Li, Lu-Ping;Schnitzer, Thomas;Du, Hongyan;Prasad, Pottumarthi V.
  • 通讯作者:
    Prasad, Pottumarthi V.
Blood oxygen level-dependent MR imaging of the kidneys.
Efficacy of preventive interventions for iodinated contrast-induced acute kidney injury evaluated by intrarenal oxygenation as an early marker.
  • DOI:
    10.1097/rli.0000000000000065
  • 发表时间:
    2014-10
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Li LP;Thacker J;Lu J;Franklin T;Zhou Y;Papadopoulou MV;Solomon R;Prasad PV
  • 通讯作者:
    Prasad PV
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

POTTUMARTHI V PRASAD其他文献

POTTUMARTHI V PRASAD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('POTTUMARTHI V PRASAD', 18)}}的其他基金

In vivo Fractional Blood Volume: Contributions to Renal BOLD MRI.
体内血容量分数:对肾脏 BOLD MRI 的贡献。
  • 批准号:
    10395426
  • 财政年份:
    2021
  • 资助金额:
    $ 32.51万
  • 项目类别:
Intrarenal Oxygenation: An Early Marker for Risk of Developing AKI
肾内氧合:发生 AKI 风险的早期标志
  • 批准号:
    9263691
  • 财政年份:
    2016
  • 资助金额:
    $ 32.51万
  • 项目类别:
Longitudinal changes in the intra-renal oxygenation by BOLD MRI in patients with
BOLD MRI 对患有以下疾病的患者肾内氧合的纵向变化
  • 批准号:
    8726380
  • 财政年份:
    2012
  • 资助金额:
    $ 32.51万
  • 项目类别:
Longitudinal changes in the intra-renal oxygenation by BOLD MRI in patients with
BOLD MRI 对患有以下疾病的患者肾内氧合的纵向变化
  • 批准号:
    8371311
  • 财政年份:
    2012
  • 资助金额:
    $ 32.51万
  • 项目类别:
Longitudinal changes in the intra-renal oxygenation by BOLD MRI in patients with
BOLD MRI 对患有以下疾病的患者肾内氧合的纵向变化
  • 批准号:
    8507728
  • 财政年份:
    2012
  • 资助金额:
    $ 32.51万
  • 项目类别:
The Intra-renal Oxygenation in CKD as evaluated by BOLD MRI
BOLD MRI 评估 CKD 肾内氧合
  • 批准号:
    7936137
  • 财政年份:
    2009
  • 资助金额:
    $ 32.51万
  • 项目类别:
The Intra-renal Oxygenation in CKD as evaluated by BOLD MRI
BOLD MRI 评估 CKD 肾内氧合
  • 批准号:
    7588686
  • 财政年份:
    2009
  • 资助金额:
    $ 32.51万
  • 项目类别:
Intra-renal Bold MRI: Application to Diabetic Nephropathy
肾内 Bold MRI:在糖尿病肾病中的应用
  • 批准号:
    7455313
  • 财政年份:
    2007
  • 资助金额:
    $ 32.51万
  • 项目类别:
Intra-renal Bold MRI: Application to Diabetic Nephropathy
肾内 Bold MRI:在糖尿病肾病中的应用
  • 批准号:
    7651400
  • 财政年份:
    2007
  • 资助金额:
    $ 32.51万
  • 项目类别:
Intra-renal Bold MRI: Application to Diabetic Nephropathy
肾内 Bold MRI:在糖尿病肾病中的应用
  • 批准号:
    7261638
  • 财政年份:
    2007
  • 资助金额:
    $ 32.51万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 32.51万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了